"the fact with this stock is it has capitulated and may well be oversold on fundamentals"
I disagree with you that this stock is oversold on 'fundamentals'.
The economics of Oposura & Alacran are unknowable until a DFS is completed and Teck earn-in saga fully resolved. Until then, all we know for sure is that any revenue streams will be years away and there'll be many dilutive CRs required to keep the company afloat til then. Impossible to assess fundamentals in this context.
Concur with the slowly boiling frog analogy. I suspect in the months ahead shareholders will look back wistfully at 19c and see it as a desirable share price.
AZS Price at posting:
19.0¢ Sentiment: Sell Disclosure: Not Held